Scandinavian Real Heart
0,283 SEK +0,71%Vær den første som følger denne virksomhed
Scandinavian Real Heart operates in medical technology. Today, the company's main focus is on research and development of heart pumps used among patients with severe heart conditions who are in the queue for transplant. The idea behind the heart pump is to use the product as a transitional solution before a final heart transplant is performed. The company is based in Västerås.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
HEART
Daglig lav / høj pris
0,28 / 0,292
SEK
Markedsværdi
58,53 mio. SEK
Aktieomsætning
48,63 t SEK
Volumen
169 t
Finanskalender
Delårsrapport
22.08.2024
Delårsrapport
14.11.2024
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
European Innovation Council Accelerator | 18,9 % | 18,9 % |
Eskilstunahem Förvaltnings AB | 8,1 % | 8,1 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Realheart performs a directed issue of units to underwriters in connection with the completed rights issue
Scandinavian Real Heart AB Announces Outcome in the Company’s Rights Issue
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools